Health Care Professionals (HCP) Presentations
VTE case studies from a clinical nursing specialist team
Dr Gillian Lowe, Dr Will Lester, Sarah Lockett & Karen Beale
Clots and COVID-19 vaccines
- Current update on VITT management
- Psychological aspects of VITT
Prof Beverley Hunt OBE, Dr Sue Pavord & Prof Paul Bennett (2022)
Ask Away on Thrombophilia
Prof Beverley Hunt OBE, Dr Karen Breen & Dr Will Thomas (2022)
Anticoagulation in VTE for primary care teams
Katherine Stirling (2022)
Evidence, discussion and recruitment in trials investigating the role of graduated compression stockings
Rebecca Lawton, Sarrah Peerbux & Matthew Machin (2022)
Gender and thrombosis (2022)
- Gender, VTE risk and effects of treatment
- Update on HRT and VTE risk
- Gender transitions and VTE risk
Prof Beverley Hunt OBE, Prof Fionnuala Ni Ainle, Dr Louise Newson & Prof Saskia Middeldorp
Direct oral anticoagulation therapy for VTE at extremes of body weight
Victoria Speed (2022)
HAT – A Welsh Update & Welsh National TP Education Project
Andrea Croft & Marilyn Rees (2022)
Hospitals review and develop action plans to common contributing factors to potentially preventable HA-VTEs
Dr Lara Roberts & panel (2022)
Developing a lower limb immobility risk assessment tool
Presented by: Andrea Croft, Lead Advanced Nurse Practitioner – Anticoagulation Wales Nurse Director – Thrombosis UK
Preventing and treating clots
Presented by: Carol Law and Rebecca Locke, VTE Education Specialists
Stockings - The GAPs Study
Presented by: Huw Rowswell, Nurse consultant in Thrombosis, University Hospitals Plymouth
Thrombosis and COVID, prevention and treatment
Presented by: Susie Shapiro, Haematology Consultant at Oxford University Hospitals
VTE Prevention-an update
Presented by: Becs Walsh, Lead Pharmacist for Anticoagulation & Thrombosis Prevention, Sheffield Teaching Hospital NHS Foundation Trust
THE RISK OF THROMBOSIS IN LONG COVID
In this tutorial, Beverley outlines the risk of thrombosis in Long COVID, including what we know so far about thrombosis risk, seated immobility syndrome which does increase risk of blood clots, and what, if anything, does a D-dimer test tell us about someone’s risk of blood clots.
BLOOD CLOTS IN ACUTE COVID-19 INFECTION
In this tutorial, Beverley discussed blood clots in acute COVID-19 infection, including who is at risk, the types of thrombosis seen, and what preventative measures are recommended for moderately and severely unwell patients.
VACCINES AND BLOOD CLOTS
In this tutorial, Beverley introduces vaccine-induced immune thrombocytopenia and thrombosis syndrome, an extremely rare immune response to a vaccine causing thrombosis (blood clots) and thrombocytopenia (low platelet count), most commonly following the Astra-Zeneca vaccine.
VTE prevention in hospitalised psychiatric patients
Chaired by: Professor Beverley Hunt OBE
Speakers:
Dr Josie Jenkinson
Dr Thomas York
Dr Ashma Mohamed
Dr Michael Cheah
Reducing hospital acquired thrombosis – Learning from NHS GIRFT (Getting It Right First Time)
Chaired by: Professor Roopen Arya
GIRFT findings - Dr Lara Roberts
Local impact and changes implemented as a result of GIRFT - Andrew Gillett
Panel discussion and Q&A session - Dr Lara Roberts, Emma Gee, Rebecca Simpson, Andrew Gillett
Identifying problem areas in thrombosis that need fresh ideas
Chaired by: Professor Beverley Hunt OBE
(a) Where are we going to improve quality and safety of imaging for VTE? - Dr Narayan Karunanithy
(b) Will we ever develop a perfect anticoagulant? - Professor Helen Philippou
(c) Improving VTE risk assessment for thromboprophylaxis in UK hospitals - Professor Roopen Arya
Learning in VTE risk assessment
Professor Roopen Arya, Lara Roberts, Marc Blondon and Banne Nemeth
Implementation of a standardised annual anticoagulation specialist review in primary care
Nathan Hutchinson-Jones
Impact of an All Wales Hospital Acquired Thrombosis Steering Group
Stephane Jaglin and Andrea Croft
Preventing VTE in Acute Care – Learning in Scotland
Health Improvement Scotland: Alison Hunter, Nada Walker, Dr Simon Watkin, Dr Andrew McClarey
Hospital Acquired Thrombosis Project Lead
Andrea Croft, Lead Advance Nurse Practitioner, Anticoagulation
Being Proactive in Preventing VTE
Professor DA Fitzmaurice, Clinical Trials Unit, University of Warwick
The Peri-Operative Management of Patients on Anticoagulation
Dr Julia Anderson, Dept of Clinical & Laboratory Haematology
Managing Anticoagulation at a Pre-Operative Assessment Clinic
Rachel Donnelly, SRN &' Sinead Doyle, MPS
Women at Risk: Who, When and Why
Dr Julia Anderson, Dept of Clinical & Laboratory Haematology
Reducing the Risk for Day Case Orthopaedic Patients
Dr Lynne Armstrong, Consultant Ortho-geriatrician
Improving prevention and best management of VTE - Reducing the risk in pregnancy
Denise Boulter, HSCNI
Reducing VTE risks from immobility, casts and braces
Dr Mark Feenan, Associate Specialist in Emergency Medicine
Recognising risk factors in patients – risk assessment and day surgery
Dr Gillian Lowe - All Scotland National Thrombosis Conference - Thursday 5 May 2016
VTE prevention and perioperative management of patients: following NICE 2018 guidance NG89’
Stephane Jaglin
Managing anticoagulation therapy for stroke prevention - who cares wins’
Prof David Fitzmaurice
Irish National Project – to reduce the risk of hospital acquired VTE
Ciara Kirke
Thromboprophylaxis with lower limb immobilisation
Mr Nurul Ahad & Mr Stephane Jaglin
Developing a modern INR service with increasingly complex patients
Nathan Hutchinson-Jones
Thromboprophylaxis in medical & surgical patients –for how long?
Dr Tamara Everington
How does a GP spot thrombosis in 600 seconds with a patient?
Dr Matthew Fay & Dr Raza Alikhan
Case studies on VTE in ambulatory care
Elaine Clark
Diagnosing DVT
Presented by: Ben Freedman, Lead clinical scientist in the vascular laboratory at King's College Hospital in London
VTE Diagnosis in the Emergency Department
Chaired by: Sylvia Teece-Round
Speaker:
Dr Dan Horner
Hospital Associated Thrombosis: the current situation in England
Professor Roopen Arya – 2016
Hospital Associated Thrombosis: the current situation in Wales
Mike Fealey - Conference - 2016
The Importance of VTE and Superficial Thrombosis for Primary and Emergency Care
Dr Matthew Fay, GP
PE Patient Case Story
Martin Yates - All England National Thrombosis Conference - Friday 6 May 2016
The role of injectable non-heparin parental anticoagulants
Chair: Prof Beverley Hunt OBE
(a) Monitoring non heparin anticoagulants from the laboratory perspective - Dr Steve Kitchen
(b) Monitoring non heparin anticoagulants from the clinical perspective - Dr Will Lester
Looking into the future of anticoagulation
Presented by: Dr Julia Czuprynska, Haematology Consultant, King's Thrombosis Team
Case history: VITT or Not VITT?
Presented by: Dr Shivir Moosai, Haematology registrar, Queen Elizabeth Hospital in Birmingham
How I treat thrombosis?
Presented by: Dr Raza Alikhan, Consultant Haematologist, Haemophilia and Thrombosis Centre, University Hospital of Wales
Clot Management in Pregnant Patient with May-Thurner Syndrome
Michelle Currie & Dr Meena Khandelwal
Clot Management in Pregnant Patient with May-Thurner Syndrome
2021 Let’s Talk Clots Trainee Doctor Case Presentation Award
Pulmonary Embolism and a Bleed
Dr Yewande Adegeye
Pulmonary Embolism and a Bleed
2021 Let’s Talk Clots conference
Trainee Doctor Case Presentation Award
COVID and clots
Chaired by: Professor Beverley Hunt OBE
(a) Current thoughts on the pathogenesis of COVID-19 - Dr Yogen Kanthi
(b) Heparin as an anti-inflammatory and antiviral agent - Dr Andrew Webb
(c) Inhaled heparin – learning and research - Dr Quentin Nunes
Update on thromboprophylaxis and COVID
Chaired by: Chaired by: Dr Mathew Fay
Update on thromboprophylaxis in hospitalised COVID-19 patients - Dr Dan Horner
Decision making on thromboprophylaxis for patients with COVID19 in the community (post discharge and those managed through a hospital at home mechanism) - Dr Susie Shapiro
Evidence update on Vaccine Induced Immune Thrombosis and Thrombocytopenia - Professor Beverley Hunt OBE
Treatment of VTE – an interactive session
Chaired by: Sylvia Teece-Round
Speaker:
Dr Will Lester
Delivery of anticoagulation management in the community, challenges and achievements
Chaired by: Sylvia Teece-Round
Speaker:
Lyndsey Stanley, Janet Davies
Managing patients on warfarin – practical tips and case studies
Chaired by: Dr Jim Moore
a) Managing skills, opportunities and challenges in a nurse led warfarin clinic - Hayley Flavell
(b) Tips and learning from an anticoagulation hospital service, pharmacist led - Victoria Collings
(c) Anticoagulation and the role of Primary Care - Dr Matthew Fay
Managing AF in the setting of COVID: Challenges and Opportunities
Chaired by: Sylvia Teece-Round
Speaker:
Dr Honey Thomas
Update on thromboprophylaxis and COVID-19
Dr Susie Shapiro, Professor Beverley Hunt OBE and Daniel Horner
Update in the use of DOACs and mechanical thromboprophylaxis
Professor Beverley Hunt OBE, Alexander Cohen and Alun Davies
The use of DOACs as the anticoagulant of choice in Primary Care
Dr Jim Moore and Matthew Fay
The role of the pharmacist in Direct Oral Anticoagulant (DOAC) management 2020
Stephane Jaglin, Rosalind Byrne and Katherine Stirling
Thrombosis in General Practice with reference to Covid-19
Dr Ken Menon, Professor Beverley Hunt OBE and Dr Sarah Crane
IT in the new era of managing patients on warfarin
Dr Kathryn Boyd, Brian Proctor, and Sharon O’Donnell
Understanding and Managing the Psychological Impact of Blood Clots
Andrea Croft and Paul Bennett
Introduction to antithrombotic medicine and management of unfractionated heparin
Kindly shared by Anthony Hackett and Jacques Strauss, Guy’s & St Thomas’ Hospital, London
How do we manage thrombotic Antiphospholipid Syndrom in 2019 ?
Dr Deepa Jayakody Arachchillage
Psychological effects of suffering a Venous Thromboembolism
Paul Bennett - 2016
Treatment Options and How They Work
Robin Offord, Director of Clinical Pharmacy, UCL Hospitals NHS Foundation Trust
>Direct Oral Anticoagulants in clinical practice: Guidance, Management, Interactions and reversal
Dr Matthew Fay - 2016
Management of Oral Anticoagulation in Frail and Complex Patients
Dr Matthew Fay - All Scotland National Thrombosis Conference - Thursday 5 May 2016
Optimisation of Anticoagulation
Dr Josephine Crowe, Nathan Jones and Sophie Didcott
Practical Tips on Initiating and Maintaining an Anticoagulation Treatment
Sue Bacon
Review of the evidence to support pharmacological thromboprophylaxis in medical and surgical patients
Dr Susie Shapiro
Managing Anticoagulation / Thromboprophylaxis in extremes of weight
Dr Jayne Peters
Management of venous thrombosis in intravenous drug users
Dr Scott Taylor & Sister Gillian Cree
LMWH prophylaxis in extremes of weight and renal impairment: a local audit
Dr Rebecca Jameson
Safety of outpatient management of Pulmonary Embolism: 2010 – 2018 in a large teaching hospital
Huw Rowswell
Making a difference in practice – A case study, Bath RUH CAT service
Dr Josephine Crowe
Anticoagulation Prescribing options & considerations Reversal agents
Dr Susie Shapiro
Antiphospholipid Syndrome, an update on managing thrombosis 2019
Prof Beverley Hunt
Warfarin self-monitoring: an option for the patient on long-term anticoagulation. Patient training process and outcomes
Deirdre Lovell
Interpreting Guidelines
Prof Simon Noble
Updates in anticoagulation for cancer associated thrombosis: what, when and for whom
Prof Simon Noble, Nathan Hutchinson-Jones
Updates in Cancer Associated Thrombosis
Dr Balaji Venugopal
Managing a Cancer Associated Thrombosis clinic – opportunities and challenges
Presented by: Nathan Hutchinson-Jones, Lead Pharmacist for Thrombosis and Anticoagulation at the Royal United Hospital (RUH) Bath
The Big Fat Audit
Presented by: Professor Simon Noble, Marie Curie Professor of Supportive and Palliative Medicine in Cardiff University and honorary consultant at the Royal Gwent Hospital in Newport
Updates in Cancer Associated Thrombosis
Professor Simon Noble, Marc Carrier and Alok Khorana
Cancer Associated Thrombosis: Burden of disease
Rt Hon. Professor the Lord Kakkar, Thrombosis Research Institute and University College London UK
Incidental VTE, Who Should We Anticoagulate?
Professor Anthony Maraveyas, Hull & East Yorkshire Hospitals
DOACs and CAT
Dr Ander Cohen, Vascular Medicine / Haematology Guy's and St Thomas' Hospitals, King's College, London
Cancer Associated thrombosis: 6 months and beyond
Dr Vickie McDonald, Consultant Haematologist Centre for Haemostasis and Thrombosis, Guys and St Thomas' NHS Foundation Trust
Anticoagulation for non-valvular AF during chemotherapy
Dr J Malcolm Walker, Consultant Cardiologist, University College London Hospitals. Founder & Clinical Director Hatter Cardiovascular Institute (HCI)
Management of CAT – Where data is Lacking
Dr Tim Nokes, Haematologist, Derriford Hospital, Plymouth
The Role of IVC Filters in CAT Management
Dr Maeve Crowley, Guys & St Thomas's
Cancer Associated Thrombosis – Palliative Care and the End of Life
Dr Tracey Anderson
Improving The Care of the Cancer Associated Thrombosis (CAT) Patient
Kieron Powers
Cancer-associated thrombosis: clinical implications arising from the experiences of cancer patients and their carers
Dr Ann Hutchinson
Conundrums in obstetrics
Dr Julia Anderson & Dr Anne Armstrong (2022)
Blood clots in pregnancy
Presented by: Dr Tessa Bonnett, Consultant Obstetrician, Jessop Wing Maternity Unit at Sheffield Teaching Hospitals NHS Trust
Management of VTE in pregnancy
Presented by: Dr Charlotte Frise, sponsored session by Cardinal Health
COVID 19 and pregnancy: the RCOG response
Dr Claire McLintock, SARS-CoV-2 COVID-19 & Pregnancy
Download Presenation
Prof S Middeldorp, Prevention of VTE in Pregnancy
Download Presenation
Dr Jan Daru, COVID-19 and Pregnancy, the RCOG response
Download Presenation
Managing Thrombosis and Pregnancy
Dr G Benson, Director NI Haemophilia and Thrombosis Unit, BHSCT, Consultant Haematologist
What’s new in obstetric prevention & management of VTE?
Prof Catherine Nelson-Piercy
Anticoagulation in pregnancy: mechanical heart valves, a case-based discussion
Dr Julia Anderson & Dr Patrick Gibson
PE – what should we do after diagnosis?
Dr Colin Church
The long-term effects of PE
Presented by: Dr Bhashkar Mukherjee, Consultant Physician in Respiratory and General (Internal) Medicine at Guy’s & St Thomas’ Hospital NHS Foundation Trust London
Early Physiotherapy Intervention Reduces the Long Term Effects of Venous Thromboembolism and Promotes an Improved Quality of Life: Results from a Pilot Study
R.Lewis, C.Entwistle and M.Robinson
Understanding and managing the psychological impact of blood clots
June 2020 - Prof Paul Bennett and Dr Rachael Hunter
Learning from a physiotherapy rehab service for PE patients
Regitsie Lewis & Chrissie Entwistle
Psychiatric and psychological support for patients with venous thromboembolism
Dr Nadine Cossette
